Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 1,442 | 2,520 | 1,999 | 1,571 | 2,170 |
| Cost of Goods | 284 | 320 | 700 | 111 | 154 |
| Gross Profit | 1,158 | 2,200 | 1,299 | 1,460 | 2,016 |
| Operating Expenses | 367,435 | -412,720 | 341,152 | 307,804 | 287,092 |
| Operating Income | -365,993 | 415,240 | -339,153 | -306,233 | -284,922 |
| Other Income | 71,429 | 38,857 | 48,784 | 147,189 | 15,660 |
| Pre-tax Income | -294,564 | 454,097 | -290,369 | -159,044 | -269,262 |
| Income Tax | -3,958 | 98,353 | 23,332 | 6,995 | 4,649 |
| Net Income Continuous | -290,606 | 355,744 | -313,701 | -166,039 | -273,911 |
| Minority Interests | -100,769 | 52,750 | -47,810 | -52,520 | -50,556 |
| Net Income | $-189,837 | $302,994 | $-265,891 | $-113,519 | $-223,355 |
| EPS Basic Total Ops | -0.26 | 0.45 | -0.38 | -0.17 | -0.33 |
| EPS Basic Continuous Ops | -0.40 | 0.52 | -0.45 | -0.24 | -0.40 |
| EPS Diluted Total Ops | -0.26 | 0.34 | -0.38 | -0.17 | -0.33 |
| EPS Diluted Continuous Ops | -0.40 | 0.52 | -0.45 | -0.24 | -0.40 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.46 | -0.36 | -0.40 | -0.30 |
| EBITDA(a) | $-365,393 | $415,878 | $-338,462 | $-305,312 | $-283,824 |